5-hydroxymethylcytosine has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cain, JE; Jayasekara, WSN; St John, JC; Sun, X; Vaghjiani, V | 1 |
| Ma, C; Teng, S; Yi, C; Yu, Y | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Osteosarcoma
| Article | Year |
|---|---|
The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma.
Topics: 5-Methylcytosine; Animals; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; DNA Copy Number Variations; DNA Methylation; DNA, Mitochondrial; Genotype; Glioblastoma; Humans; Immunoprecipitation; Mice; Mitochondria; Neoplasm Transplantation; Osteosarcoma; Whole Genome Sequencing | 2018 |
Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells.
Topics: 5-Methylcytosine; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Hydroxyurea; Mixed Function Oxygenases; Osteosarcoma; Proto-Oncogene Proteins; Up-Regulation | 2019 |